Acelrx Pharmaceuticals reported $51.75M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 51.75M 7.22M
Acura Pharmaceuticals ACUR:US 1.31M 70K
Baxter International BAX:US $ 8167M 163M
Becton, Dickinson and BDX:US $ 8838M 700M
Biodelivery Sciences International BDSI:US $ 188.26M 7.8M
Cara Therapeutics CARA:US $ 171.5M 7.03M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Intra Cellular Therapies ITCI:US $ 533.24M 68.06M
Pain Therapeutics PTIE:US $ 251.92M 27.64M
Smiths SMIN:LN 2.74B 117M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Xeris Pharmaceuticals Inc XERS:US $ 124.37M 20.22M
Zogenix ZGNX:US $ 375.46M 40.93M